New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

January 2014

January 8

Farxiga (dapagliflozin) Tablets

Date of Approval: January 8, 2014
Company: Bristol-Myers Squibb Company and AstraZeneca
Treatment for: Diabetes Type 2

Farxiga (dapagliflozin) is a selective sodium-glucose cotransporter-2 inhibitor for the treatment of adults with type 2 diabetes mellitus.

Farxiga (dapagliflozin) FDA Approval History

January 9

Mekinist (trametinib)

New Indication Approved: January 9, 2014

Mekinist (trametinib) FDA Approval History

January 29

Copaxone (glatiramer acetate)

New Dosage Form Approved: January 28, 2014

January 31

Hetlioz (tasimelteon) Capsules

Date of Approval: January 31, 2014
Company: Vanda Pharmaceuticals Inc.
Treatment for: Non-24-Hour Disorder

Hetlioz (tasimelteon) is a melatonin receptor agonist for the treatment of Non-24-Hour Disorder in the totally blind.

Hetlioz (tasimelteon) FDA Approval History

January 31

Retin-A Micro (tretinoin)

New Dosage Form Approved:

Hide
(web2)